XEOMIN® is made through a unique precision manufacturing process that isolates the therapeutic component of the molecule and removes the accessory proteins that don’t play an active role in treatment. XEOMIN® is a highly purified neurotoxin.
XEOMIN® (incobotulinumtoxinA) is a highly purified neurotoxin, precision manufactured in a world-class facility using advanced technology. The active ingredient of XEOMIN® is botulinum toxin type A, produced from fermentation of Hall strain Clostridium botulinum serotype A. Merz takes the toxin complex and employs a proprietary manufacturing process that isolates the therapeutic component and removes the accessory proteins to produce XEOMIN®. Accessory proteins accompany the active neurotoxin but do not play an active role in treatment. The clinical significance of a lack of accessory proteins, including any impact on safety or efficacy, has not been established.
Botulinum toxin (type A)- 900 kDa XEOMIN® - 150 kDa